145 related articles for article (PubMed ID: 38427506)
1. Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis.
Wang B; Yan M; Liu C; Yang Z; Wang X; Zhao F; Wang Z; Li P; Wang Y; Li S; Liu G; Liu P
NeuroRehabilitation; 2024; 54(2):213-225. PubMed ID: 38427506
[TBL] [Abstract][Full Text] [Related]
2. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
Dornhoffer JR; Plitt AR; Lohse CM; Driscoll CLW; Neff BA; Saoji AA; Van Gompel JJ; Link MJ; Carlson ML
Otol Neurotol; 2024 Jan; 45(1):29-35. PubMed ID: 37875011
[TBL] [Abstract][Full Text] [Related]
3. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
4. Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(4):1-85. PubMed ID: 32190165
[TBL] [Abstract][Full Text] [Related]
5. Auditory outcomes in tumor vs. nontumor patients fitted with auditory brainstem implants.
Colletti V
Adv Otorhinolaryngol; 2006; 64():167-185. PubMed ID: 16891842
[TBL] [Abstract][Full Text] [Related]
6. Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
Khneisser E; Bussieres R; Côté M; Philippon D; Fradet G; Côté M; Lessard N; Champagne PO; Trudel M
Otol Neurotol; 2023 Sep; 44(8):e621-e627. PubMed ID: 37550875
[TBL] [Abstract][Full Text] [Related]
7. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
8. Auditory Brainstem Implantation in Chinese Patients With Neurofibromatosis Type II: The Hong Kong Experience.
Thong JF; Sung JK; Wong TK; Tong MC
Otol Neurotol; 2016 Aug; 37(7):956-62. PubMed ID: 27273391
[TBL] [Abstract][Full Text] [Related]
9. Options and strategies for hearing restoration in pediatric neurofibromatosis type 2.
Mahboubi H; Slattery WH; Mehta GU; Lekovic GP
Childs Nerv Syst; 2020 Oct; 36(10):2481-2487. PubMed ID: 32564156
[TBL] [Abstract][Full Text] [Related]
10. Auditory brainstem implants for neurofibromatosis type 2.
Colletti L; Shannon R; Colletti V
Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
[TBL] [Abstract][Full Text] [Related]
11. Novel Statistical Analyses to Assess Hearing Outcomes After ABI Implantation in NF2 Patients: Systematic Review and Individualized Patient Data Analysis.
Taslimi S; Zuccato JA; Mansouri A; Hachem LD; Badhiwala J; Kuchta J; Chen J; Pirouzmand F
World Neurosurg; 2019 Aug; 128():e669-e682. PubMed ID: 31059859
[TBL] [Abstract][Full Text] [Related]
12. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
13. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
[TBL] [Abstract][Full Text] [Related]
14. English consensus protocol evaluating candidacy for auditory brainstem and cochlear implantation in neurofibromatosis type 2.
Tysome JR; Axon PR; Donnelly NP; Evans DG; Ferner RE; O'Connor AF; Freeman SR; Gleeson M; Halliday D; Harris F; Jiang D; Kerr R; King A; Knight RD; Lloyd SK; Macfarlane R; Mannion R; Mawman D; O'Driscoll M; Parry A; Ramsden J; Ramsden R; Rutherford SA; Saeed SR; Thomas N; Vanat ZH
Otol Neurotol; 2013 Dec; 34(9):1743-7. PubMed ID: 24136318
[TBL] [Abstract][Full Text] [Related]
15. Auditory Brainstem Implantation in Neurofibromatosis Type 2: Experience From the Manchester Programme.
Ramsden RT; Freeman SR; Lloyd SK; King AT; Shi X; Ward CL; Huson SM; Mawman DJ; O'Driscoll MP; Evans DG; Rutherford SA;
Otol Neurotol; 2016 Oct; 37(9):1267-74. PubMed ID: 27525707
[TBL] [Abstract][Full Text] [Related]
16. Auditory brainstem implants (ABIs)--20 years of clinical experience in Uppsala, Sweden.
Siegbahn M; Lundin K; Olsson GB; Stillesjö F; Kinnefors A; Rask-Andersen H; Nyberg G
Acta Otolaryngol; 2014 Oct; 134(10):1052-61. PubMed ID: 24881643
[TBL] [Abstract][Full Text] [Related]
17. New outcomes with auditory brainstem implants in NF2 patients.
Behr R; Colletti V; Matthies C; Morita A; Nakatomi H; Dominique L; Darrouzet V; Brill S; Shehata-Dieler W; Lorens A; Skarzynski H
Otol Neurotol; 2014 Dec; 35(10):1844-51. PubMed ID: 25325841
[TBL] [Abstract][Full Text] [Related]
18. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
Colletti L
Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
[TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis 2: hearing restoration options.
Monteiro TA; Goffi-Gomez MV; Tsuji RK; Gomes MQ; Brito Neto RV; Bento RF
Braz J Otorhinolaryngol; 2012 Oct; 78(5):128-34. PubMed ID: 23108832
[TBL] [Abstract][Full Text] [Related]
20. Auditory brainstem implantation in patients with neurofibromatosis type 2.
Kanowitz SJ; Shapiro WH; Golfinos JG; Cohen NL; Roland JT
Laryngoscope; 2004 Dec; 114(12):2135-46. PubMed ID: 15564834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
